PT  - JOURNAL ARTICLE
AU  - Flórez-Delgado, Nancy Yaneth
AU  - Ubillus, Elizabeth Noelia
AU  - Perez-Sepulveda, Blanca
AU  - Ospina-Ríos, Eyda Lizeth
AU  - Carrascal-Camacho, Ana Karina
AU  - Chamorro-Tobar, Iliana C
AU  - Montaño, Lucy Angeline
AU  - Li, Yan
AU  - Zapata-Bedoya, Silvana
AU  - Hinton, Jay C.D.
AU  - Villarreal, José Miguel
AU  - Wiesner, Magdalena
TI  - Class 1 integrons in clinical and swine industry isolates of <em>Salmonella</em> Typhimurium from Colombia, dating 1997 to 2017
AID  - 10.1101/2022.02.14.22270819
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.02.14.22270819
4099  - http://medrxiv.org/content/early/2022/02/15/2022.02.14.22270819.short
4100  - http://medrxiv.org/content/early/2022/02/15/2022.02.14.22270819.full
AB  - Background Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) has been linked to outbreaks of foodborne gastroenteritis disease, and the emergence of antimicrobial-resistant clones. In Colombia, laboratory surveillance of Salmonella spp. between 1997-2018 revealed that S. Typhimurium was the most ubiquitous serovar (27.57% of all Salmonella isolates), with increasing levels of antimicrobial resistance to several families of antibiotics. Hypothesis. Resistant isolates of S. Typhimurium recovered from clinical and swine samples carry class 1 integrons that are linked to antimicrobial resistance genes. Aim. Identify class 1 integrons, and investigate their association with other mobile genetic elements, and their relationship to the antimicrobial resistance of Colombian S. Typhimurium isolates. Methods. In this study, 392 clinical isolates of S. Typhimurium were analyzed, of which 237 were obtained from blood culture, 155 from non-invasive sources and 50 isolates from swine of which 32 were obtained from a slaughterhouse, 10 from a point of sale and 8 from cutting plant. Class 1 integrons and plasmid incompatibility groups were analyzed by PCR and Whole Genome Sequencing (WGS), and the region surrounding of the integrons identified by WGS. The phylogenetic relationship was established by MLST and SNP analysis. Results. Overall, 39.03% (153/392) of the clinical isolates and 22% (11/50) of the swine S. Typhimurium isolates carried complete class 1 integrons. Twelve types of gene cassette arrays were identified, including dfr7-aac-blaOXA-2 (Int1-Col1) as the most frequent in clinical isolates (75.2% = 115/153). Clinical and swine isolates that carried class 1 integrons were resistant to up to 5 and up to 3 antimicrobial families, respectively. The Int1-Col1 integron was most prevalent in stool isolates and was associated with Tn21. The most common plasmid incompatibility group was IncA/C. Conclusions. The widespread presence of the integron (IntI1-Col1) in Colombia since 1997 was striking. We speculate that the relationship between integrons, source and mobile elements favors the dispersion of antibiotic resistance determinants in Colombian S. Typhimurium isolates.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by COLCIENCIAS (SIGP 210471250745), COLCIENCIAS (Project no. 120358635758), the Ministerio de Agricultura y Desarrollo Rural (MADR) Convenio no. 20150360, PUJ PP-ID: 00006737, PY-ID: 00006865 and by the internal funds of the National Institute of Health, Colombia. N.Y.F-D. is supported by the special agreement of scientific and technological cooperation no. 014/14 of 2014 between Antonio Narino University and the National Institute of Health, Colombia. E.N.U. is supported by ICETEX Scholarship Reciprocity Program for Foreigners in Colombia. To Andres Montilla for his support with the WGS test of a sample. Genome sequencing was performed at the Earlham Institute as part of the 10KSG consortium which is supported by the Global Challenges Research Fund data and resources grant (BBS/OS/GC/000009D). Next-generation sequencing and library construction were delivered via the BBSRC National Capability in Genomics and Single Cell (BB/CCG1720/1) at Earlham Institute, by members of the Genomics Pipelines Group.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research has the approval of the Technical Research Committee (CTIN) and the Ethics Research Committee (CEIN) of the Instituto Nacional de Salud (INS), Colombia with the codes CTIN-05-2015 and CTIN-05-2017. Clinical and patient ID from whom the S. Typhimurium clinical isolates were recovered, were anonymized.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript